Revealing a New Hope
![ASCO 2023: Game-Changing Results Unveiled: Zanidatamab Shows Promise in HER2-Amplified Biliary Tract Cancers, Revealing a New Hope](https://pharmtales.com/wp-content/uploads/2023/06/ASCO-2023-Game-Changing-Results-Unveiled-Zanidatamab-Shows-Promise-in-HER2-Amplified-Biliary-Tract-Cancers-Revealing-a-New-Hope.jpg)
ASCO 2023: Zanidatamab – A New Hope for HER2-Amplified Biliary Tract Cancers
SG Tylor
ABSTRACT NUMBER – 4008 A subset of biliary tract cancer cases presents either with overexpression or amplification of the HER2 ...
ABSTRACT NUMBER – 4008 A subset of biliary tract cancer cases presents either with overexpression or amplification of the HER2 ...